Impact BioMedical

Impact BioMedical Improving health outcomes in innovative ways based on nature's wisdom.

03/17/2025

Did you miss the recent announcement about our acquisition of Celios?

We invite you to listen in as we detail what this acquisition means for the future of Impact Biomedical and how we will continue to pursue additional opportunities in the health and wellness space to increase shareholder value for all!

&A

Impact BioMedical's COO, Mark Suseck, will be attending BIO CEO next week in NYC! If you'll be in town, let’s connect—re...
02/06/2025

Impact BioMedical's COO, Mark Suseck, will be attending BIO CEO next week in NYC! If you'll be in town, let’s connect—reach out to schedule a meeting and we look forward to great conversations! 💬🔬

01/23/2025

Debt Restructuring Enhances Financial Flexibility and Extends Cash Runway!

Listen in as Impact BioMedical CEO, Frank Heuszel, details how the team restructured their long-term debt obligations as part of their IPO strategy. This approach provides greater financial flexibility, enabling the company to retain more cash for R&D and near-term expenses—driving innovation and future growth!

01/14/2025

What You WON’T Hear at the J.P. Morgan Healthcare Conference…

Discover Impact BioMedical’s game-changing vision for 2025! 🚀

Listen in as our executive team unveils their outlook for the year ahead, including diverse milestones across our entire product platform. See why Impact BioMedical is strategically positioned for breakthrough success in 2025.

🎧 Don’t miss out—listen below!

12/05/2024

✨ ICYMI: Catch the Impact BioMedical (NYSE American: IBO) management team as they delve into their four core platform technologies and explain how these align with the company’s unique business model! ✨

Happy Memorial Day from Impact Biomedical! Today, we honor all those who have served and sacrificed for our country. Tha...
05/27/2024

Happy Memorial Day from Impact Biomedical! Today, we honor all those who have served and sacrificed for our country. Thank you for your courage and commitment. Their selflessness and unwavering dedication inspire us all. 🇺🇸

Happy Easter from Impact Biomedical, Inc. Wishing you a joyous and blessed holiday filled with hope and renewal. Thank y...
03/31/2024

Happy Easter from Impact Biomedical, Inc. Wishing you a joyous and blessed holiday filled with hope and renewal. Thank you for your continued support of our mission to make a positive impact on global health.

Impact Biomedical is dedicated to leveraging the latest advancements in technology for critical research towards creatin...
03/25/2024

Impact Biomedical is dedicated to leveraging the latest advancements in technology for critical research towards creating a healthier world.

Our continuous commitment to staying at the forefront of tech trends allows us to make significant strides in our mission.

Learn more at impactbiomedinc.com

Happy Presidents' Day from DSS, Inc. As we spend today reflecting on the leadership that came before us, let's honor the...
02/19/2024

Happy Presidents' Day from DSS, Inc. As we spend today reflecting on the leadership that came before us, let's honor their legacy by channeling their ingenuity and strength to serve our families and communities with even greater passion and dedication.

As we approach Thanksgiving Day, we would like to take a moment to express our heartfelt gratitude to all those who have...
11/23/2023

As we approach Thanksgiving Day, we would like to take a moment to express our heartfelt gratitude to all those who have supported us throughout the year.

In the coming year, we look forward to even greater achievements, challenges to conquer, and successes to celebrate together.

We wish you and your loved ones a warm and joyful Thanksgiving.

Impact Biomedical, a human healthcare and wellness company and subsidiary of DSS, Inc. (NYSE American: DSS), has filed a...
11/09/2023

Impact Biomedical, a human healthcare and wellness company and subsidiary of DSS, Inc. (NYSE American: DSS), has filed a Current Report on Form 8K on November 6, 2023, disclosing that Impact effected a reverse stock split of its issued and outstanding common stock by a ratio of 1 for 55.

“Existing Impact common stockholders, who previously held approximately 12% of the outstanding common stock of Impact, will now hold approximately 88% of the company’s common stock shares.”

-Frank Heuszel, CEO of DSS, Inc.

Learn more → https://finance.yahoo.com/news/dss-inc-subsidiary-files-current-133100219.html

Address

1400 Broadfield Boulevard , Suite 130
Houston, TX
77084

Alerts

Be the first to know and let us send you an email when Impact BioMedical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share